Tekla Healthcare Investors – NYSE:HQH

Tekla Healthcare Investors stock price today

$16.75
+0.28
+1.76%
Financial Health
0
1
2
3
4
5
6
7
8
9

Tekla Healthcare Investors stock price monthly change

-9.46%
month

Tekla Healthcare Investors stock price quarterly change

-9.46%
quarter

Tekla Healthcare Investors stock price yearly change

-0.12%
year

Tekla Healthcare Investors key metrics

Market Cap
788.59M
Enterprise value
795.85M
P/E
14.01
EV/Sales
9.60
EV/EBITDA
6.48
Price/Sales
9.60
Price/Book
0.78
PEG ratio
0.14
EPS
2.88
Revenue
97.61M
EBITDA
143.13M
Income
142.61M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
71.74%
Oper. margin
87.3%
Gross margin
93.48%
EBIT margin
87.3%
EBITDA margin
146.64%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Tekla Healthcare Investors stock price history

Tekla Healthcare Investors stock forecast

Tekla Healthcare Investors financial statements

Tekla Healthcare Investors (NYSE:HQH): Profit margin
Mar 2023 25.20M 83.16M 329.94%
Jun 2023 2.33M -13.41M -575.22%
Sep 2023 75.23M -26.82M -35.66%
Mar 2024 -5.16M 99.69M -1930.08%
Tekla Healthcare Investors (NYSE:HQH): Debt to assets
Mar 2023 990763738 11.67M 1.18%
Jun 2023 932491693 1.14M 0.12%
Sep 2023 932491693 1.14M 0.12%
Mar 2024 1008790426 1.10M 0.11%
Tekla Healthcare Investors (NYSE:HQH): Cash Flow
Dec 2022 0 0 0
Mar 2023 0 0 0
Jun 2023 0 0 0
Sep 2023 0 0 0

Tekla Healthcare Investors other data

Tekla Healthcare Investors (NYSE:HQH): Insider trades (number of shares)
Period Buy Sel
Sep 2023 19000 0
Dec 2023 1170 0
Jan 2024 1000 0
Apr 2024 525 0
Jul 2024 1000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
DIMARTINO ROSE director
Common Stock 1,000 $18.88 $18,880
Purchase
GOETZ KATHLEEN director
Common Stock 525 $16.42 $8,623
Purchase
REIT TODD director
Common Stock 1,000 $16.93 $16,929
Purchase
MAHER BILL director
Common Stock 1,000 $16.58 $16,580
Purchase
GOODSON ALAN R officer: Vice President
Common stock 170 $16.13 $2,742
Purchase
OMSTEAD DANIEL R director, officer: President
Shares of Beneficial Interest 9,500 $15.63 $148,514
Purchase
OMSTEAD DANIEL R director, officer: President
Shares of Beneficial Interest 9,500 $15.88 $150,832
Purchase
GOETZ KATHLEEN director:
Shares of Beneficial Interest 73 $20.42 $1,490
Purchase
GOETZ KATHLEEN director
Shares of Beneficial Interest 481 $21.52 $10,349
Purchase
OMSTEAD DANIEL R director, officer: President
Shares of Beneficial Interest 5,200 N/A N/A
Tuesday, 24 December 2024
forbes.com
Sunday, 15 December 2024
seekingalpha.com
Saturday, 30 November 2024
seekingalpha.com
Thursday, 21 November 2024
seekingalpha.com
Friday, 1 November 2024
seekingalpha.com
Friday, 6 September 2024
seekingalpha.com
Monday, 19 August 2024
seekingalpha.com
Friday, 9 August 2024
accesswire.com
Wednesday, 17 July 2024
seekingalpha.com
seekingalpha.com
Saturday, 13 July 2024
seekingalpha.com
Wednesday, 26 June 2024
accesswire.com
Monday, 10 June 2024
seekingalpha.com
Monday, 20 May 2024
https://www.defenseworld.net
Saturday, 11 May 2024
Seeking Alpha
Wednesday, 8 May 2024
Seeking Alpha
Thursday, 7 March 2024
Seeking Alpha
Sunday, 3 March 2024
Seeking Alpha
Saturday, 2 March 2024
Seeking Alpha
Sunday, 25 February 2024
Seeking Alpha
Sunday, 4 February 2024
Seeking Alpha
Wednesday, 31 January 2024
Seeking Alpha
Friday, 26 January 2024
Seeking Alpha
Tuesday, 16 January 2024
Seeking Alpha
Friday, 5 January 2024
Seeking Alpha
Thursday, 21 December 2023
Seeking Alpha
Tuesday, 19 December 2023
Seeking Alpha
Wednesday, 15 November 2023
Seeking Alpha
Tuesday, 31 October 2023
Seeking Alpha
Thursday, 5 October 2023
Seeking Alpha
  • What's the price of Tekla Healthcare Investors stock today?

    One share of Tekla Healthcare Investors stock can currently be purchased for approximately $16.75.

  • When is Tekla Healthcare Investors's next earnings date?

    Unfortunately, Tekla Healthcare Investors's (HQH) next earnings date is currently unknown.

  • Does Tekla Healthcare Investors pay dividends?

    Yes, Tekla Healthcare Investors pays dividends and its trailing 12-month yield is 13.85% with 0% payout ratio. The last Tekla Healthcare Investors stock dividend of $0.51 was paid on 31 Dec 2021.

  • How much money does Tekla Healthcare Investors make?

    Tekla Healthcare Investors has a market capitalization of 788.59M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 105.35% to 10.29M US dollars.

  • What is Tekla Healthcare Investors's stock symbol?

    Tekla Healthcare Investors is traded on the NYSE under the ticker symbol "HQH".

  • What is Tekla Healthcare Investors's primary industry?

    Company operates in the Financial Services sector and Asset Management industry.

  • How do i buy shares of Tekla Healthcare Investors?

    Shares of Tekla Healthcare Investors can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • When Tekla Healthcare Investors went public?

    Tekla Healthcare Investors is publicly traded company for more then 38 years since IPO on 23 Apr 1987.

  • What is Tekla Healthcare Investors's official website?

    The official website for Tekla Healthcare Investors is teklacap.com.

  • Where are Tekla Healthcare Investors's headquarters?

    Tekla Healthcare Investors is headquartered at 100 Federal Street, Boston, MA.

  • How can i contact Tekla Healthcare Investors?

    Tekla Healthcare Investors's mailing address is 100 Federal Street, Boston, MA and company can be reached via phone at +61 77728500.

Tekla Healthcare Investors company profile:

Tekla Healthcare Investors

teklacap.com
Exchange:

NYSE

Full time employees:

0

Industry:

Asset Management

Sector:

Financial Services

Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States.

100 Federal Street
Boston, MA 02110

CIK: 0000805267
ISIN: US87911J1034
CUSIP: 87911J103